DOI:
10.1055/s-00029025
Journal of Pediatric Epilepsy
LinksClose Window
References
Waubant E, Banwell B, Wassmer E. , et al; IPMSSG.
Clinical trials of disease-modifying agents in pediatric MS: opportunities, challenges, and recommendations from the IPMSSG.
Neurology 2019;
92 (22) e2538-e2549
We do not assume any responsibility for the contents of the web pages of other providers.